Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Clinical ChemistryOpen Access

B-327 Measurable Residual Disease Monitoring at Acute Myeloid Leukemia Based on Laboratory Data

View Full Paper
Ask AI
Bookmark
Share

Authors

SASheila Siqueira AndradeJMJulia MariniAVAndressa Vaz

Discussion

Loading...

Member takes

Overview

Retrospective analysis evaluates MRD in acute myeloid leukemia patients using flow cytometry, suggesting its critical role in treatment guidance.

Key Points

  • MRD analysis demonstrates essential predictive value for treatment outcomes in acute myeloid leukemia patients.
  • 56% of the analyzed patients were female, with the highest incidence seen in those aged 50 and above.
  • Multiparametric flow cytometry was the primary technique used for MRD detection across various sample types.
  • LAIP characterization revealed lineage infidelity in 40.4% of cases, underscoring the complexity of AML monitoring.

Cite This Study

Andrade et al. (2025) studied this question.

synapsesocial.com/papers/68e040e9a99c246f578b303chttps://doi.org/10.1093/clinchem/hvaf086.714
View Full Paper
Ask AI
Bookmark
Share